Comparative assessment of prognostic outcomes between first-generation antiandrogens and novel androgen-receptor-axis-targeted agents in patients with non-metastatic castration-resistant prostate cancer
暂无分享,去创建一个
H. Miyake | Hiromitsu Watanabe | Toshiki Ito | A. Otsuka | T. Sugiyama | K. Tamura | Y. Matsushita | D. Motoyama